Induction therapy-2 cycles of VPX (Teniposide, PD-1 monoclonal antibody plus Selinixor)
2024474
Unknown small_molecule active
Quick answer
Induction therapy-2 cycles of VPX (Teniposide, PD-1 monoclonal antibody plus Selinixor) for Primary Central Nervous System Lymphoma (PCNSL) is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Primary Central Nervous System Lymphoma (PCNSL)
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active